Tech Company Financing Transactions
Sparta Biomedical Funding Round
Private investors invested in a venture round for Sparta Biomedical. The round was announced by the company on 9/12/2023.
Transaction Overview
Company Name
Announced On
9/12/2023
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The secured capital will accelerate the company's preparations for the Investigational Device Exemption study preparations of its breakthrough device, Ormi.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Main Street 202
Madison, NJ 07940
USA
Madison, NJ 07940
USA
Phone
Undisclosed
Website
Email Address
Overview
Sparta is creating the first-of-its-kind chemically engineered cartilage platform, Galene. The degeneration of cartilage between the joints can cause significant personal, economic, societal burden for individuals, families, and communities. In addition, acute injuries to joint cartilage can exacerbate and become debilitating over time. We are developing cartilage-like implants for the knee and all of the important joints in the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dushyanth Surakanti
Chief Operating Officer
Dimitrios Angelis
Chief Technical Officer
Benjamin Wiley
Browse more venture capital transactions:
Prev: 9/12/2023: BioLamina venture capital transaction
Next: 9/12/2023: Cleafy venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs